Remix Therapeutics Enters Collaboration with Roche for the Discovery and Development of Small Molecule Therapeutics Modulating RNA Processing
WATERTOWN, Mass., Jan. 3, 2024 /PRNewswire/ — Remix Therapeutics (Remix), a clinical stage biotechnology company developing small molecule therapies to modulate RNA processing …